Abstract
In a 51-year-old woman affected by breast cancer, hepatic recurrence of disease was managed by concurrent Y-90-labeled glass microsphere embolization (transarterial radioembolization) and radiofrequency thermoablation. Intention-to-treat target, candidate to radioembolization, was in the IV hepatic segment; another lesion, managed with radiofrequency thermoablation, was in the VI-VII hepatic segment. Concomitant correction of a duodenocephalopancreatic shunting was performed as well. Thermoablation did not interfere with distribution of Tc-99m-macroaggregated albumin and Y-90-labeled microspheres to the target and healthy liver. At our knowledge, this is the first report that combines 2 locoregional procedures in different hepatic segments on the same day.
| Original language | English |
|---|---|
| Pages (from-to) | 446-448 |
| Number of pages | 3 |
| Journal | Clinical Nuclear Medicine |
| Volume | 48 |
| DOIs | |
| Publication status | Published - 2023 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Y-90-labeled microspheres
- hepatic malignancies
- radioembolization
- thermoablation with radiofrequencies
- transarterial radioembolization
Fingerprint
Dive into the research topics of 'Synchronous Treatment of Breast Cancer Hepatic Metastases by Transarterial Radioembolization and Radiofrequency Thermoablation: A Case Report'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver